Mahitosh Mandal

22PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 30, 2026
Coupling DNA intercalation with redox catalysis: selective killing mechanism of glioblastoma by daidzin.

|Feb 16, 2026
Targeting of HSP27 and MMP-2/9 Crosstalk by High-Throughput Drug Repurposing Strategies Identifies Paroxetine as a Potential Candidate in Glioblastoma.

Suvendu Nandi, Shreya Banerjee, Debolina Manna

|Oct 31, 2025
Modified PAMAM Dendrimer-Based Carboplatin Delivery in Glioblastoma: In Vitro and In Vivo Studies.

Madhurima Mandal, Dipanjan Samanta, Debolina Manna

|Apr 21, 2025
Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations.

Madhurima Mandal, Indranil Banerjee, Mahitosh Mandal

|Mar 11, 2025
Fabrication of Folic Acid-Derived Carbon Dot-Conjugated Chitosan Nanospheres as Theragnostic Agents for pH-Responsive Anticancer Drug Delivery.

Trisita Ghosh, Madhurima Mandal, Moumita Shee

|Feb 13, 2025
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting.

Priya Ghosh, Ankita Dey, Suvendu Nandi

Pageof 4

Frequent Collaborators

6 joint publications

Subhayan Das

4 joint publications

Suvendu Nandi

4 joint publications

Indranil Banerjee

2 joint publications

Subhas C Kundu